Stamford, CT, United States of America

E Douglas Kramer

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of E Douglas Kramer in Cancer Treatment

Introduction

E Douglas Kramer, an accomplished inventor based in Stamford, CT, has made significant strides in the field of pharmaceutical innovations. With a portfolio of five patents, his work primarily focuses on enhancing cancer treatment methodologies and improving patient outcomes.

Latest Patents

Among his notable contributions, two of Kramer's latest patents stand out. The first is a groundbreaking therapeutic combination of orally administered irinotecan and a P-glycoprotein (P-gp) inhibitor, aimed at treating cancer effectively. This innovative combination seeks to reduce or prevent toxicity and hypersensitivity-type infusion reactions linked to intravenously administered irinotecan therapy in cancer patients. The second patent addresses methods for treating and preventing actinic keratosis, wherein Kramer's formulation involves administering a therapeutically effective amount of KX-01 to individuals in need of such treatment.

Career Highlights

Kramer's illustrious career has seen him work with prominent companies in the pharmaceutical sector, including Athenex Hk Innovative Limited and Athenex, Inc. His expertise in the development of innovative treatment combinations and methodologies has positioned him as a key figure in the fight against cancer.

Collaborations

Throughout his career, E Douglas Kramer has enjoyed fruitful collaborations with esteemed colleagues, including Min-Fun Rudolf Kwan and Johnson Yiu-Nam Lau. These partnerships have strengthened his research efforts, leading to the advancement of therapeutic solutions that hold promise for patients battling cancer and related conditions.

Conclusion

In conclusion, E Douglas Kramer's contributions to pharmaceutical innovation, particularly in cancer treatment, underscore the importance of addressing patient needs through scientific advancements. His work exemplifies the spirit of innovation and showcases the impact that dedicated inventors can have on improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…